Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African–Americans with opioid use disorder
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African–Americans with opioid use disorder
Authors
Keywords
-
Journal
PHARMACOGENOMICS JOURNAL
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-27
DOI
10.1038/s41397-018-0065-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alternative Splicing of the Delta-Opioid Receptor Gene Suggests Existence of New Functional Isoforms
- (2018) Marjo Piltonen et al. MOLECULAR NEUROBIOLOGY
- Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1
- (2017) A H Smith et al. MOLECULAR PSYCHIATRY
- Context and craving during stressful events in the daily lives of drug-dependent patients
- (2017) Kenzie L. Preston et al. PSYCHOPHARMACOLOGY
- A polymorphism in the OPRM1 3′-untranslated region is associated with methadone efficacy in treating opioid dependence
- (2016) R C Crist et al. PHARMACOGENOMICS JOURNAL
- Genome-Wide Pharmacogenomic Study on Methadone Maintenance Treatment Identifies SNP rs17180299 and Multiple Haplotypes on CYP2B6, SPON1, and GSG1L Associated with Plasma Concentrations of Methadone R- and S-enantiomers in Heroin-Dependent Patients
- (2016) Hsin-Chou Yang et al. PLoS Genetics
- Clonidine Maintenance Prolongs Opioid Abstinence and Decouples Stress From Craving in Daily Life: A Randomized Controlled Trial With Ecological Momentary Assessment
- (2015) William J. Kowalczyk et al. AMERICAN JOURNAL OF PSYCHIATRY
- HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease
- (2015) Lucas D. Ward et al. NUCLEIC ACIDS RESEARCH
- The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
- (2015) et al. SCIENCE
- Topiramate Treatment for Heavy Drinkers: Moderation by aGRIK1Polymorphism
- (2014) Henry R. Kranzler et al. AMERICAN JOURNAL OF PSYCHIATRY
- Assessment of CYP450 genetic variability effect on methadone dose and tolerance
- (2014) Hui-Ju Tsai et al. PHARMACOGENOMICS
- Impact of ABCB1 and CYP2B6 Genetic Polymorphisms on Methadone Metabolism, Dose and Treatment Response in Patients with Opioid Addiction: A Systematic Review and Meta-Analysis
- (2014) Brittany B. Dennis et al. PLoS One
- A commonly carried genetic variant in the delta opioid receptor gene,OPRD1,is associated with smaller regional brain volumes: Replication in elderly and young populations
- (2013) Florence F. Roussotte et al. HUMAN BRAIN MAPPING
- Role of Cytochrome P4502B6 in Methadone Metabolism and Clearance
- (2013) Evan D. Kharasch et al. JOURNAL OF CLINICAL PHARMACOLOGY
- An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans
- (2013) Richard C Crist et al. NEUROPSYCHOPHARMACOLOGY
- Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis
- (2012) Antonio-Javier Chamorro et al. ADDICTION BIOLOGY
- Case–control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with cocaine and opioid addicted populations
- (2012) R.C. Crist et al. DRUG AND ALCOHOL DEPENDENCE
- Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: A randomized trial
- (2012) Andrew J. Saxon et al. DRUG AND ALCOHOL DEPENDENCE
- Pharmacokinetic-Pharmacodynamic Modeling of Mood and Withdrawal Symptoms in Relation to Plasma Concentrations of Methadone in Patients Undergoing Methadone Maintenance Treatment
- (2012) Mohammad-Reza Shiran et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The NIH Roadmap Epigenomics Program data resource
- (2012) Lisa Helbling Chadwick Epigenomics
- CYP2B6SNPs are associated with methadone dose required for effective treatment of opioid addiction
- (2011) Orna Levran et al. ADDICTION BIOLOGY
- Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United States
- (2011) Howard G. Birnbaum et al. PAIN MEDICINE
- Role of CYP2B6 in Stereoselective Human Methadone Metabolism
- (2009) Rheem A. Totah et al. ANESTHESIOLOGY
- Real-Time Electronic Diary Reports of Cue Exposure and Mood in the Hours Before Cocaine and Heroin Craving and Use
- (2009) David H. Epstein et al. ARCHIVES OF GENERAL PSYCHIATRY
- An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol Dependence
- (2008) Raymond F. Anton et al. ARCHIVES OF GENERAL PSYCHIATRY
- Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency
- (2008) David H. Epstein et al. DRUG AND ALCOHOL DEPENDENCE
- BDNFvariability in opioid addicts and response to methadone treatment: preliminary findings
- (2008) R. de Cid et al. GENES BRAIN AND BEHAVIOR
- ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence
- (2008) Orna Levran et al. HUMAN MOLECULAR GENETICS
- Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment
- (2008) Séverine Crettol et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now